🔎 Trials Near Me

Hjem › KOLS › California › Newport Beach

Kliniske studier for KOLS i Newport Beach, CA

8 studier for KOLS søker deltakere på steder i og rundt Newport Beach (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

RekruttererFase 2
  • NewportNativeMD, Inc., Newport Beach
Alder 40 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Newport Native MD- Site Number : 8400003, Newport Beach
Alder 40 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07190209

A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)

RekruttererFase 3
  • Newport Native MD- Site Number : 8403003, Newport Beach
Alder 40 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07793409

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2
  • Research Site, Newport Beach
Alder 40 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

RekruttererFase 3
  • Research Site, Newport Beach
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2/3
  • NewportNativeMD, Inc., Newport Beach
Alder 35 til 80 · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07363694

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

RekruttererFase 3
  • GSK Investigational Site, Newport Beach
Alder 40 til 75 · Alle kjønn · Oppdatert 28. jul. 2026 · NCT07177339

KOLS-studier i andre byer

Andre studier i Newport Beach

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.